Biotest Diagnostics Corporation Announces Appointment of Director of Sales, Transfusion Diagnostics

2009-01-12 16:52:03 -

Biotest Diagnostics Corporation (BDC), a subsidiary of Biotest AG, a worldwide supplier of manual and automated solutions to the blood bank industry, announces the appointment of John T. Beck to the newly created position of Director of Sales, Transfusion Diagnostics. In his new position at Biotest, Mr. Beck will be responsible for sales management of the Biotest Manual Blood Group Serology Reagents and the TANGO ® optimo Automated Blood Bank System. Mr. Beck will also be involved in strategic planning and forecasting.


Mr. Beck has a strong history in the blood bank industry having previously worked at Immucor in research and development, sales, marketing management, and sales management. While at Immucor, he played a leading role in the launch of blood bank instrumentation and established a highly successful track record as a sales representative and sales manager.


"With the recent U.S. Food and Drug Administration licensure of our Traditional Blood Bank Reagents, along with the growing market acceptance of the TANGO optimo Automated Blood Bank System, Biotest is well-positioned to become a leading supplier to the blood bank market," said Bill Weiss, President of Biotest Diagnostics Corporation. "Mr. Beck's extensive experience selling and marketing blood bank instrumentation and reagents, will enable him to effectively lead the Biotest sales team to achieve that goal."


Headquartered in Rockaway, N.J., Biotest Diagnostics Corporation is the U.S. subsidiary of Biotest AG. Biotest supports two product groups: Laboratory Diagnostics and Industrial Microbiology. An innovator of immunology, the Diagnostics Group spearheads the development of traditional and automated solutions for transplant and transfusion diagnostics. The Microbiology Group assists customers in the monitoring and maintaining of quality assurance programs in their industries while also providing a one-stop shop for environmental monitoring needs, including a complete line of prepared culture media and solutions for air sampling, particle counting and surface testing. For more information about Biotest's blood typing and testing solutions, call 800-522-0090, e-mail info@BiotestUSA.com or visit Biotest at www.BiotestUSA.com.





Biotest Diagnostics Corporation

Candace Williams, 973-625-1300

Candace.Williams@BiotestUSA.com